Greater access to life-changing medicine for Australians with ADHD
Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS). On 1 February, the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are diagnosed with ADHD after they turn…